Primary care engagement is associated with increased pharmacotherapy prescribing for alcohol use disorder (AUD)
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1940-0640
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Primary care engagement is associated with increased pharmacotherapy prescribing for alcohol use disorder (AUD) ; volume:14 ; number:1 ; day:1 ; month:5 ; year:2019 ; pages:1-7 ; date:12.2019
Addiction science & clinical practice ; 14, Heft 1 (1.5.2019), 1-7, 12.2019
- Creator
-
Joudrey, Paul J.
Kladney, Mat
Cunningham, Chinazo O.
Bachhuber, Marcus A.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13722-019-0147-3
- URN
-
urn:nbn:de:101:1-2019051319131539178406
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:50 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Joudrey, Paul J.
- Kladney, Mat
- Cunningham, Chinazo O.
- Bachhuber, Marcus A.
- SpringerLink (Online service)
Other Objects (12)
Endpoints for Pharmacotherapy Trials for Alcohol Use Disorder
Prescribing Pharmacotherapy for Major Depressive Disorder: How Does a Clinician Decide?
Pharmacotherapy for alcohol use disorder among adults with medical disorders in Sweden
Quadruple pharmacotherapy for alcohol use disorder tolerable yet insufficient: a case report
Medication underuse in older outpatients : a pharmacoepidemiological approach towards an optimized pharmacotherapy using explicit prescribing criteria
Pharmacotherapy in glaucoma
Pharmacotherapy of obesity
Pharmacotherapy for Nocturia
From pharmaco-therapy to pharmaco-prevention: trends in prescribing to older adults in Ontario, Canada, 1997-2006
How useful are prescribing indicators based on the DU90% method to distinguish the quality of prescribing between pharmacotherapy audit meetings with different levels of functioning?
Involvement of Fibroblast Growth Factor 2 (FGF-2) in Alcohol Use Disorder (AUD)
Rhinitis: immunopathology and pharmacotherapy
Endpoints for Pharmacotherapy Trials for Alcohol Use Disorder
Prescribing Pharmacotherapy for Major Depressive Disorder: How Does a Clinician Decide?
Pharmacotherapy for alcohol use disorder among adults with medical disorders in Sweden
Quadruple pharmacotherapy for alcohol use disorder tolerable yet insufficient: a case report
Medication underuse in older outpatients : a pharmacoepidemiological approach towards an optimized pharmacotherapy using explicit prescribing criteria
Pharmacotherapy in glaucoma
Pharmacotherapy of obesity
Pharmacotherapy for Nocturia
From pharmaco-therapy to pharmaco-prevention: trends in prescribing to older adults in Ontario, Canada, 1997-2006
How useful are prescribing indicators based on the DU90% method to distinguish the quality of prescribing between pharmacotherapy audit meetings with different levels of functioning?
Involvement of Fibroblast Growth Factor 2 (FGF-2) in Alcohol Use Disorder (AUD)
Rhinitis: immunopathology and pharmacotherapy
Endpoints for Pharmacotherapy Trials for Alcohol Use Disorder
Prescribing Pharmacotherapy for Major Depressive Disorder: How Does a Clinician Decide?
Pharmacotherapy for alcohol use disorder among adults with medical disorders in Sweden
Quadruple pharmacotherapy for alcohol use disorder tolerable yet insufficient: a case report
Medication underuse in older outpatients : a pharmacoepidemiological approach towards an optimized pharmacotherapy using explicit prescribing criteria
Pharmacotherapy in glaucoma
Pharmacotherapy of obesity
Pharmacotherapy for Nocturia
From pharmaco-therapy to pharmaco-prevention: trends in prescribing to older adults in Ontario, Canada, 1997-2006
How useful are prescribing indicators based on the DU90% method to distinguish the quality of prescribing between pharmacotherapy audit meetings with different levels of functioning?
Involvement of Fibroblast Growth Factor 2 (FGF-2) in Alcohol Use Disorder (AUD)